Sivik Global Healthcare LLC / BMRN
Sivik Global Healthcare LLC’s Biomarin Pharmaceutical Inc Position
Does Sivik Global Healthcare LLC own Biomarin Pharmaceutical Inc (BMRN)? Not currently — the last reported position was 57.5K shares worth $5M in Q1 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$5M
Q1 2024
Shares
57.5K
% of Portfolio
+1.18%
Quarters Held
22
position exited
Position History BMRN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2024 | 57.5K | $5M | +1.18% |
| Q4 2023 | 55.0K | $5M | +2.22% |
| Q3 2023 | 50.0K | $4M | +2.24% |
| Q2 2023 | 50.0K | $4M | +1.01% |
| Q1 2023 | 50.0K | $5M | +2.09% |
| Q4 2022 | 60.0K | $6M | +2.92% |
| Q3 2022 | 55.0K | $5M | +2.59% |
| Q2 2022 | 47.5K | $4M | +2.24% |
| Q1 2022 | 40.0K | $3M | +1.27% |
| Q4 2021 | 40.0K | $4M | +1.51% |
| Q3 2021 | 65.0K | $5M | +1.20% |
| Q2 2021 | 55.0K | $5M | +0.90% |
| Q1 2021 | 60.0K | $5M | +1.65% |
| Q4 2020 | 80.0K | $7M | +2.86% |
| Q3 2020 | 65.0K | $5M | +2.13% |
| Q2 2020 | 220.0K | $8M | +2.69% |
| Q1 2020 | 235.0K | $8M | +3.31% |
| Q4 2019 | 80.0K | $7M | +2.51% |
| Q3 2019 | 45.0K | $3M | +1.53% |
| Q2 2019 | 35.0K | $3M | +0.72% |
| Q1 2019 | 45.0K | $4M | +1.47% |
| Q4 2018 | 55.0K | $5M | +2.52% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sivik Global Healthcare LLC’s full portfolio or all institutional holders of BMRN.